Pieges et conseils a propos de l'utilisation des antidiabetiques oraux conventionnels.

Acidosis, Lactic/etiology/prevention & control; Administration, Oral; Aged; Diabetes Mellitus, Type 2/drug therapy; Humans; Hypoglycemia/drug therapy/etiology; Hypoglycemic Agents/adverse effects/therapeutic use; Male; Metformin/adverse effects/therapeutic use; Sulfonylurea Compounds/adverse effects/therapeutic use

Abstract :

[en] The main pitfalls regarding the use of sulphonylureas and metformin in type 2 diabetic patients are described and illustrated by a clinical case. Advices are given in order to avoid the occurrence of severe hypoglycaemic episodes with sulphonylureas and to minimise the risk of lactic acidosis with metformin. These drugs, when used appropriately with respect of contra-indications, have an excellent safety profile and remain the basis of the treatment of type 2 diabetes.

Disciplines :

Endocrinology, metabolism & nutrition
Pharmacy, pharmacology & toxicology

Author, co-author :

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Language :

French

Title :

Pieges et conseils a propos de l'utilisation des antidiabetiques oraux conventionnels.

Alternative titles :

[en] Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs

Publication date :

2002

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

352-6

Peer reviewed :

Peer reviewed

Additional URL :

http://www.rmlg.ulg.ac.be

Available on ORBi :

since 08 April 2009

Statistics

Number of views

892 (3 by ULiège)

Number of downloads

954 (7 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Groop L.C. (1992) Sulfonylureas and NIDDM. Diabetes Care 15:737-754.
Scheen A.J. (1996) Les sulfamides hypoglycémiants, 50 ans après Loubatières. Rev Med Liège 51:90-93.
Cusi K., DeFronzo R.A. (1998) Metformin: A review of its metabolic effects. Diabetes Rev 6:89-131.
Johansen K. (1999) Efficacy of metformin in the treatment of NIDDM. Meta-analysis. Diabetes Care 22:33-37.
Scheen A.J. (2001) Le répaglinide (NovoNorm®). Rev Med Liège 56:456-459.
Scheen A.J., Charbonnel B. (2001) Effets antidiabètiques des thiazolidinediones. Méd Thérapeut Endocrinol 3(SUPPL. 2):41-48.
Scheen A.J., Lefèbvre P.J. (1998) Oral antidiabetic agents: A guide to selection. Drugs 55:225-236.
Lefèbvre P.J. (1995) Comment j'explore ... Un patient suspect d'hypoglycémie. Rev Med Liège 50:131-132.
Miller C.D., Phillips L.S., Ziemer D.C. (2001) Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 161:1653-1659.
Campbell I.W. (1993) Hypoglycemia and type II diabetes: Sulfonylureas. Hypoglycemia and diabetes: Clinical and physiological aspects , Frier B, Fisher M, ed. Edward Arnold, London; 387-392.
Stahl M., Berger W. (1995) Sulfonylursées: Pharmacologie et risque hypoglycémique. Journées de Diabétologie de l'Hôtel-Dieu , Flammarion Médecine-Sciences, Paris; 108-119.
Burge M.R., Schmitz-Fiorentino K., Fischette C. (1998) A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus. JAMA 279:137-143.
Scheen A.J., Lefèbvre P.J. (1995) Antihyperglycaemic agents. Drug interactions of clinical importance. Drug Safety 12:32-45.
Scheen A.J. (2000) Le glimépiride (Amarylle®). Rev Med Liège 55:184-186.
Damsbo P., Clauson P., Marbury T.C., Windfeld K. (1999) A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients. Diabetes Care 22:789-794.
Larsen J.J., Dela F., Madsbad S. (1999) Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care 22:1647-1654.
Scheen A.J., Paquot N., Lefèbvre P.J. (1997) Comment j'explore ... Nouveaux critères pour le diagnostic du diabète sucré. Rev Med Liège 52:606-609.
Scheen A.J. (1998) Les leçons de la "United Kingdom Prospective Diabetes Study". Rev Med Liège 53:576-578.
Scheen A.J., Paquot N. (1999) Le diabète de type 2: Approaches diagnostiques, objectifs glycémiques et stratégies thérapeutiques. Rev Med Liège 54:659-666.
Scheen A.J. (1997) Particularités de la pharmacothérapie chez le sujet âgé. Rev Med Liège 52:201-204.
Weekers L., Scheen A.J., Lefèbvre P.J. (1998) Comment j'explore ... La néphropathie diabétique. Deuxième partie: Suivi de la filtration glomérulaire. Rev Med Liège 53:571-575.
Scheen A.J. (1996) Clinical pharmacokinetics of metformin. Clin Pharmacokin 30:359-371.
Lalau J.D., Race J.M. (2001) Lactic acidosis in metformin therapy: Searching for a link with metformin in reports of "metformin-associated lactic acidosis". Diabetes Obesity Metab 3:195-201.